Patents-Review.com
ClassID:

242675 ⎘

Y10S514/912 - CPC Classification

Classification description:

Sub-classes:
Recent Application in this class:
#1
20220218669
2022-07-14

COMPOSITIONS AND METHODS FOR NON-SURGICAL TREATMENT OF PTOSIS

 #2
20210244741
2021-08-12

Methods of treating eye diseases associated with inflammation and vascular proliferation

 #3
20210113458
2021-04-22

SUSTAINED DRUG DELIVERY IMPLANT

 #4
20200360345
2020-11-19

COMPOSITIONS AND METHODS FOR NON-SURGICAL TREATMENT OF PTOSIS

 #5
20200237916
2020-07-30

OPHTHALMIC FORMULATION AND METHOD FOR AMELIORATING PRESBYOPIA

 #6
20200188336
2020-06-18

PHARMACOLOGY OF VISUAL CYCLE MODULATORS

 #7
20200054757
2020-02-20

CYCLOSPORIN COMPOSITIONS

 #8
20200009114
2020-01-09

Compositions and methods for non-surgical treatment of ptosis

 #9
20190209467
2019-07-11

SUSTAINED DRUG DELIVERY IMPLANT

 #10
20190133986
2019-05-09

METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION

 #11
20190029986
2019-01-31

THERAPEUTIC REGIMEN AND METHODS FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY

 #12
20180338953
2018-11-29

Compositions and Methods for Non-Surgical Treatment of Ptosis

 #13
20180117049
2018-05-03

Methods of treating eye diseases associated with inflammation and vascular proliferation

 #14
20180098955
2018-04-12

METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION

 #15
20180008556
2018-01-11

RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF

 #16
20170216281
2017-08-03

Optical correction

 #17
20170093100
2017-03-30

Movable wall panel system with electrical connections

 #18
20170087114
2017-03-30

Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency

 #19
20170056399
2017-03-02

Sustained drug delivery implant

 #20
20160331713
2016-11-17

Methods for the treatment and prevention of age-related retinal dysfunction

 #21
20160199386
2016-07-14

Methods of treating thyroid eye disease

 #22
20160045453
2016-02-18

Stabilized mutant opsin proteins

 #23
20160038465
2016-02-11

Compositions and methods for non-surgical treatment of Ptosis

 #24
20150290215
2015-10-15

Methods for treating diseases of the retina

 #25
20150165050
2015-06-18

Cyclosporin compositions

 #26
20150133415
2015-05-14

Ophthalmic compositions and methods for treating ophthalmic conditions

 #27
20150057327
2015-02-26

Ketorolac tromethamine compositions for treating or preventing ocular pain

 #28
20140378519
2014-12-25

Optical correction

 #29
20140378506
2014-12-25

Compositions and methods for treatment

 #30
20140371265
2014-12-18

Compositions and methods for treatment

 #31
20140303091
2014-10-09

Ocular formulations of norketotifen

 #32
20140234390
2014-08-21

Sustained drug delivery implant

 #33
20140161872
2014-06-12

Compositions and methods for treatment

 #34
20140141062
2014-05-22

Compositions and methods for treatment

 #35
20140057958
2014-02-27

Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases

 #36
20140057855
2014-02-27

Cyclosporin compositions

 #37
20140056997
2014-02-27

Use of low molecular weight amino alcohols in ophthalmic compositions

 #38
20140039058
2014-02-06

Ophthalmic solution

 #39
20140031298
2014-01-30

Compositions and methods for localized therapy of the eye

 #40
20140030337
2014-01-30

Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye

 #41
20140024642
2014-01-23

Ophthalmic formulation and method for ameliorating presbyopia

 #42
20140011753
2014-01-09

Cyclosporin compositions

 #43
20130197051
2013-08-01

Ketorolac tromethamine compositions for treating or preventing ocular pain

 #44
20130196950
2013-08-01

Retinoid replacements and opsin agonists and methods for the use thereof

 #45
20130096131
2013-04-18

Optical correction

 #46
20130072568
2013-03-21

Retinoid replacements and opsin agonists and methods for the use thereof

 #47
20130072557
2013-03-21

Methods for the treatment and prevention of age-related retinal dysfunction

 #48
20130059841
2013-03-07

THERAPEUTIC COMPOSITIONS AND METHODS

 #49
20130032757
2013-02-07

UV-absorbers for ophthalmic lens materials

 #50
20120329902
2012-12-27

Methods for the preparation of biocompatible polymers, the polymers and their uses

 #51
20120322891
2012-12-20

Retinoid replacements and opsin agonists and methods for the use thereof

 #52
20120310144
2012-12-06

VISION THROUGH PHOTODYNAMIC THERAPY OF THE EYE

 #53
20120259008
2012-10-11

Method for treating asthenopia

 #54
20120253300
2012-10-04

Method, device, and system for delivery of therapeutic agents to the eye

 #55
20120238632
2012-09-20

MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION

 #56
20120232119
2012-09-13

Method for treating a keratoconjunctival disorder

 #57
20120232019
2012-09-13

Compositions and methods for treatment of eye disorders

 #58
20120231065
2012-09-13

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

 #59
20120225947
2012-09-06

RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNIT

 #60
20120225920
2012-09-06

Compositions and methods for non-surgical treatment of ptosis

 #61
20120225919
2012-09-06

Compositions and methods for non-surgical treatment of ptosis

 #62
20120225918
2012-09-06

Compositions and Methods for Non-Surgical Treatment of Ptosis

 #63
20120196868
2012-08-02

Therapeutic compositions and methods

 #64
20120190722
2012-07-26

Ketorolac tromethamine compositions for treating or preventing ocular pain

 #65
20120190705
2012-07-26

Methods of inhibiting choroidal neovascularization

 #66
20120149746
2012-06-14

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases

 #67
20120142746
2012-06-07

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure

 #68
20120142675
2012-06-07

Methods for treating diseases of the retina

 #69
20120142652
2012-06-07

COMPOSITIONS AND METHODS FOR LOCALIZED THERAPY OF THE EYE

 #70
20120136036
2012-05-31

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions

 #71
20120122945
2012-05-17

Ester pro-drugs of [3-(1-(-imidazol-4-yl)ethyl)-2-methylphenyl] methanol

 #72
20120116216
2012-05-10

Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

 #73
20120115959
2012-05-10

Therapeutic Compositions And Methods

 #74
20120115829
2012-05-10

Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection

 #75
20120088739
2012-04-12

METHOD FOR TREATING MEIBOMIAN GLAND DISEASE

 #76
20120083147
2012-04-05

Movable wall panel system with electrical connections

 #77
20120077769
2012-03-29

Topical ophthalmic compositions containing tobramycin and dexamethasone

 #78
20120071485
2012-03-22

Therapeutic Compositions And Methods

 #79
20120064123
2012-03-15

Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye

 #80
20120041073
2012-02-16

Stabilized mutant opsin proteins

 #81
20120035148
2012-02-09

OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC CONDITIONS

 #82
20120034278
2012-02-09

OPHTHALMIC PREPARATION CONTAINING MENTHYL ESTER OF INDOMETHACIN

 #83
20120021991
2012-01-26

Use of a botulinum neurotoxin to alleviate various disorders

 #84
20120015001
2012-01-19

Methods of treating thyroid eye disease

 #85
20110306661
2011-12-15

Hydrogel contact lens for sustained drug release and drug release method using hydrogel contact lens for sustained drug release

 #86
20110295034
2011-12-01

Eye drop composition containing isopropyl unoprostone

 #87
20110272645
2011-11-10

UV-absorbers for ophthalmic lens materials

 #88
20110257266
2011-10-20

Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency

 #89
20110184062
2011-07-28

Compositions and methods for dry eye syndrome

 #90
20110165229
2011-07-07

Compositions and methods for treatment

 #91
20110165228
2011-07-07

Compositions and methods for treatment

 #92
20110137228
2011-06-09

Use of Green Porphyrins to Treat Neovasculature in the Eye

 #93
20110112066
2011-05-12

Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof

 #94
20110071629
2011-03-24

Ultra violet, violet, and blue light filtering polymers for ophthalmic applications

 #95
20110039805
2011-02-17

METHOD FOR TREATING MEIBOMIAN GLAND DISEASE

 #96
20110038832
2011-02-17

METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE

 #97
20110020337
2011-01-27

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

 #98
20110008462
2011-01-13

SYSTEM AND METHOD FOR THERAPEUTIC APPLICATION OF DISSOLVED OXYGEN

 #99
20110003895
2011-01-06

Pharmacology of visual cycle modulators

 #100
20100331407
2010-12-30

Clear ophthalmic solution comprising latanoprost as active ingredient

 #101
20100330164
2010-12-30

Method of increasing tear production with purinergic receptor agonists

 #102
20100310642
2010-12-09

Topical drug delivery systems for ophthalmic use

 #103
20100286078
2010-11-11

Topical ophthalmic compositions containing tobramycin and dexamethasone

 #104
20100274215
2010-10-28

Flushing solution

 #105
20100249134
2010-09-30

Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina

 #106
20100227904
2010-09-09

Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye

 #107
20100222369
2010-09-02

TREATMENT FOR DRY EYE CONDITIONS

 #108
20100204194
2010-08-12

Superoxide dismutase mimics for the treatment of ocular disorders and diseases

 #109
20100204127
2010-08-12

Use of a botulinum neurotoxin to alleviate various disorders

 #110
20100179117
2010-07-15

Superoxide dismutase mimics for the treatment of ocular disorders and diseases

 #111
20100168121
2010-07-01

COMPOUNDS WITH 5-HT1A ACTIVITY USEFUL FOR TREATING DISORDERS OF THE OUTER RETINA

 #112
20100130550
2010-05-27

Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen

 #113
20100092542
2010-04-15

Compositions and methods for treatment of eye disorders

 #114
20100092541
2010-04-15

COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS

 #115
20100075941
2010-03-25

Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof

 #116
20100074899
2010-03-25

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

 #117
20100035986
2010-02-11

Methods for the treatment and prevention of age-related retinal dysfunction

 #118
20100012889
2010-01-21

UV-absorbers for ophthalmic lens materials

 #119
20090264523
2009-10-22

Method for prevention of degradation of thermally unstable medicament

 #120
20090239947
2009-09-24

Inhibition of proliferation and fibrotic response of activated corneal stromal cells

 #121
20090239842
2009-09-24

Solutions containing epinastin

 #122
20090233890
2009-09-17

Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

 #123
20090220573
2009-09-03

Method, device, and system for delivery of therapeutic agents to the eye

 #124
20090196846
2009-08-06

Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid

 #125
20090156606
2009-06-18

OPTICAL CORRECTION

 #126
20090105313
2009-04-23

Method for treating a keratoconjunctival disorder

 #127
20090087481
2009-04-02

Methods of treating neurological conditions with hematopoeitic growth factors

 #128
20090054532
2009-02-26

Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation

 #129
20090054531
2009-02-26

Eye drop preparation comprising xanthan gum and terpenoid

 #130
20090043090
2009-02-12

Adduct of fluorescent dye and tumor avid tetrapyrrole

 #131
20090036479
2009-02-05

METHOD OF INHIBITING CHOROIDAL NEOVASCUARIZATION

 #132
20090029920
2009-01-29

Methods and compositions for treating ocular disorders

 #133
20080279814
2008-11-13

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

 #134
20080241232
2008-10-02

Use of green porphyrins to treat neovasculature in the eye

 #135
20080241097
2008-10-02

Methods of treating neurological conditions with hematopoeitic growth factors

 #136
20080214510
2008-09-04

Methods and compositions for treating meibomian gland disease

 #137
20080181865
2008-07-31

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

 #138
20080175894
2008-07-24

Methods of treating neurological conditions with hematopoeitic growth factors

 #139
20080171080
2008-07-17

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

 #140
20080146553
2008-06-19

Antibiotic compostions and methods for using same

 #141
20080118592
2008-05-22

Use of a botulinum neurotoxin to alleviate various disorders

 #142
20080103211
2008-05-01

USE OF BETA-ADRENOCEPTOR ANTAGONISTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISORDERS OF THE OUTER RETINA

 #143
20080096966
2008-04-24

Ophthalmic compositions containing diglycine

 #144
20080090914
2008-04-17

Staining composition for staining an ophthalmic membrane

 #145
20080075687
2008-03-27

Ophthalmic compositions containing a synergistic combination of three polymers

 #146
20080070908
2008-03-20

Compositions including antibiotics and methods for using same

 #147
20080070834
2008-03-20

Cyclosporin compositions

 #148
20080058403
2008-03-06

Vision through photodynamic therapy of the eye

 #149
20080027120
2008-01-31

Ketorolac tromethamine compositions for treating or preventing ocular pain

 #150
20080009476
2008-01-10

Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva

 #151
20080009463
2008-01-10

Method of treating dry eye disease with purinergic receptor agonists

 #152
20080009436
2008-01-10

Cyclosporin compositions

 #153
20070265247
2007-11-15

METHOD OF REDUCING CONTACT LENS INTOLERANCE WITH NON-DRYING ANTIHISTAMINES

 #154
20070232523
2007-10-04

Therapeutic compositions of oncomodulin

 #155
20070231294
2007-10-04

Ophthalmic compositions containing a synergistic combination of three polymers

 #156
20070224159
2007-09-27

Ophthalmic compositions containing a synergistic combination of three polymers

 #157
20070207121
2007-09-06

Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration

 #158
20070197503
2007-08-23

Solutions containing epinastin

 #159
20070185082
2007-08-09

TREATING RHINITIS BY TOPICALLY ADMINISTERING AN EPINASTINE SOLUTION TO THE NASAL MUCOUS MEMBRANE

 #160
20070172483
2007-07-26

Methods for treating conditions associated with MASP-2 dependent complement activation

 #161
20070149447
2007-06-28

Cyclosporin compositions

 #162
20070116777
2007-05-24

Ophthalmic preparation containing menthyl ester of indomethacin

 #163
20070110826
2007-05-17

Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision

 #164
20070099865
2007-05-03

Treatment of dry eye conditions

 #165
20070098677
2007-05-03

OPHTHALMIC COMPOSITIONS CONTAINING GALACTOMANNAN POLYMERS AND BORATE

 #166
20070087046
2007-04-19

Use of green porphyrins to treat neovasculature in the eye

 #167
20070065442
2007-03-22

Compositions and methods for treating hyperimmune response in the eye

 #168
20070043025
2007-02-22

Method of treating dry eye disease with non-drying antihistamines

 #169
20070021503
2007-01-25

OPHTHALMIC FLUID

 #170
20070015710
2007-01-18

Cyclosporin compositions

 #171
20070015694
2007-01-18

Cyclosporin compositions

 #172
20070015692
2007-01-18

Cyclosporin compositions

 #173
20070015690
2007-01-18

Cyclosporin compositions

 #174
20060286267
2006-12-21

Baby-food compositions enhancing visual acuity and methods therefor

 #175
20060281821
2006-12-14

Retinoid replacements and opsin agonists and methods for the use thereof

 #176
20060281739
2006-12-14

Compositions and methods for treatment of eye disorders

 #177
20060280715
2006-12-14

Retinoid solutions and formulations made therefrom

 #178
20060276458
2006-12-07

Therapeutic compositions and methods

 #179
20060264516
2006-11-23

Use of low molecular weight amino alcohols in ophthalmic compositions

 #180
20060252844
2006-11-09

Ultra violet, violet, and blue light filtering polymers for ophthalmic applications

 #181
20060229283
2006-10-12

Cholesterol as an antibiotic for

#182
20060205709
2006-09-14

Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof

 #183
20060204591
2006-09-14

Treatment of mucosal membranes

 #184
20060199868
2006-09-07

Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina

 #185
20060189669
2006-08-24

Pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy

 #186
20060183729
2006-08-17

Vanadium compounds as anti-angiogenic agents

 #187
20060183727
2006-08-17

Estrogenic compounds as anti-mitotic agents

 #188
20060154901
2006-07-13

Methods for treating ocular rosacea

 #189
20060148905
2006-07-06

Methods for treatment of beta-amyloid protein-induced ocular disease

 #190
20060105047
2006-05-18

Novel prepolymers useful in biomedical devices

 #191
20060094063
2006-05-04

Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation

 #192
20060089361
2006-04-27

Methods for treating retinal diseases

 #193
20060088530
2006-04-27

Photodynamic therapy treatment for eye disease

 #194
20060083792
2006-04-20

Therapeutic treatments using the direct application of antimicrobial metal compositions

 #195
20060079576
2006-04-13

Estrogenic compounds as anti-mitotic agents

 #196
20060079482
2006-04-13

Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same

 #197
20060069162
2006-03-30

Transparent eye drops containing latanoprost

 #198
20060035880
2006-02-16

Superoxide dismutase mimics for the treatment of ocular disorders and diseases

 #199
20060034822
2006-02-16

Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vitreous body of the eye

 #200
20060025386
2006-02-02

Method of treatment of retinal ischemia with diazoxide

 #201
20060009498
2006-01-12

Ophthalmic compositions and methods for treating ophthalmic conditions

 #202
20060009415
2006-01-12

Corneal epithelial migration promoter

 #203
20060008443
2006-01-12

Ophthalmic compositions for lubricating eyes and methods for making and using same

 #204
20050288274
2005-12-29

Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane

 #205
20050282715
2005-12-22

Use of multifunctional surface active agents to clean contact lenses

 #206
20050271743
2005-12-08

Treatment of inflammatory skin conditions

 #207
20050256129
2005-11-17

Compounds with 5-HTactivity useful for treating disorders of the outer retina

 #208
20050256083
2005-11-17

Preserved pharmaceutical compositions comprising cyclodextrins

 #209
20050255130
2005-11-17

Retinoid solutions and formulations made therefrom

 #210
20050250778
2005-11-10

Topical brimonidine tartrate formulations that lack chlorine dioxide

 #211
20050250681
2005-11-10

Treatment of ocular diseases and disorders using lantibiotic compositions

 #212
20050239900
2005-10-27

Use of low molecular weight amino alcohols in ophthalmic compositions

 #213
20050222265
2005-10-06

Ophthalmic solution

 #214
20050203121
2005-09-15

Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases

 #215
20050197316
2005-09-08

Method of enhancing drainage of lacrimal system with purinergic receptor agonists

 #216
20050197296
2005-09-08

Agents for preventing and treating thrombocytopenia

 #217
20050192322
2005-09-01

Calcium blockers to treat proliferative vitreoretinopathy

 #218
20050187241
2005-08-25

Method of inhibiting choroidal neovascularization

 #219
20050181017
2005-08-18

Compositions and methods for localized therapy of the eye

 #220
20050175613
2005-08-11

Compositions and methods for treating hyperimmune response in the eye

 #221
20050158387
2005-07-21

Olopatadine formulations for topical administration

 #222
20050152960
2005-07-14

Use of green porphyrins to treat neovasculature in the eye

 #223
20050136130
2005-06-23

Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision

 #224
20050129782
2005-06-16

Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions

 #225
20050118281
2005-06-02

Ionic silver complex

 #226
20050100579
2005-05-12

Novel prepolymers useful in biomedical devices

 #227
20050075313
2005-04-07

Ophthalmic compositions containing galactomannan polymers and borate

 #228
20050074504
2005-04-07

Use of borate-polyol complexes in ophthalmic compositions

 #229
20050069531
2005-03-31

Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders

 #230
20050054558
2005-03-10

Methods and compositions for treating ocular disorders

 #231
20050053713
2005-03-10

Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions

 #232
20050047270
2005-03-03

System and method for therapeutic application of dissolved oxygen

 #233
20050032768
2005-02-10

Superoxide dismutase mimics for the treatment of ocular disorders and diseases

 #234
20050020555
2005-01-27

Estrogenic compounds as anti-mitotic agents

 #235
10799299
2015-03-17

Night vision composition